vs

Side-by-side financial comparison of Armada Hoffler Properties, Inc. (AHH) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.

Armada Hoffler Properties, Inc. is the larger business by last-quarter revenue ($75.6M vs $70.6M, roughly 1.1× Viridian Therapeutics, Inc.\DE). Armada Hoffler Properties, Inc. runs the higher net margin — 3.1% vs -49.0%, a 52.2% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 0.8%).

Armada Hoffler Properties, Inc. is a publicly traded U.S. real estate investment trust operating across the Mid-Atlantic and Southeast regions. It develops, owns, and manages a diversified portfolio of office, retail, and multifamily residential properties, and also offers construction and development services for third-party clients.

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

AHH vs VRDN — Head-to-Head

Bigger by revenue
AHH
AHH
1.1× larger
AHH
$75.6M
$70.6M
VRDN
Growing faster (revenue YoY)
VRDN
VRDN
+81957.4% gap
VRDN
81958.1%
0.8%
AHH
Higher net margin
AHH
AHH
52.2% more per $
AHH
3.1%
-49.0%
VRDN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AHH
AHH
VRDN
VRDN
Revenue
$75.6M
$70.6M
Net Profit
$2.4M
$-34.6M
Gross Margin
Operating Margin
31.0%
-56.7%
Net Margin
3.1%
-49.0%
Revenue YoY
0.8%
81958.1%
Net Profit YoY
-89.8%
54.9%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHH
AHH
VRDN
VRDN
Q4 25
$75.6M
Q3 25
$72.7M
$70.6M
Q2 25
$69.1M
Q1 25
$67.8M
Q4 24
$75.0M
Q3 24
$114.4M
Q2 24
$116.8M
Q1 24
$127.0M
Net Profit
AHH
AHH
VRDN
VRDN
Q4 25
$2.4M
Q3 25
$80.0K
$-34.6M
Q2 25
$5.9M
Q1 25
$-2.8M
Q4 24
$23.4M
Q3 24
$-5.0M
Q2 24
$3.2M
Q1 24
$14.1M
Gross Margin
AHH
AHH
VRDN
VRDN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
45.0%
Q2 24
41.8%
Q1 24
37.9%
Operating Margin
AHH
AHH
VRDN
VRDN
Q4 25
31.0%
Q3 25
29.2%
-56.7%
Q2 25
29.6%
Q1 25
23.2%
Q4 24
50.1%
Q3 24
19.0%
Q2 24
11.9%
Q1 24
15.1%
Net Margin
AHH
AHH
VRDN
VRDN
Q4 25
3.1%
Q3 25
0.1%
-49.0%
Q2 25
8.6%
Q1 25
-4.1%
Q4 24
31.2%
Q3 24
-4.4%
Q2 24
2.7%
Q1 24
11.1%
EPS (diluted)
AHH
AHH
VRDN
VRDN
Q4 25
$0.00
Q3 25
$-0.04
Q2 25
$0.04
Q1 25
$-0.07
Q4 24
$0.28
Q3 24
$-0.11
Q2 24
$0.00
Q1 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHH
AHH
VRDN
VRDN
Cash + ST InvestmentsLiquidity on hand
$49.1M
$490.9M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$627.8M
$503.0M
Total Assets
$2.6B
$577.1M
Debt / EquityLower = less leverage
2.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHH
AHH
VRDN
VRDN
Q4 25
$49.1M
Q3 25
$46.5M
$490.9M
Q2 25
$52.1M
Q1 25
$45.7M
Q4 24
$31.9M
Q3 24
$43.9M
Q2 24
$20.3M
Q1 24
$41.9M
Total Debt
AHH
AHH
VRDN
VRDN
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.4B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
AHH
AHH
VRDN
VRDN
Q4 25
$627.8M
Q3 25
$638.8M
$503.0M
Q2 25
$652.0M
Q1 25
$657.4M
Q4 24
$670.6M
Q3 24
$663.9M
Q2 24
$562.7M
Q1 24
$571.4M
Total Assets
AHH
AHH
VRDN
VRDN
Q4 25
$2.6B
Q3 25
$2.6B
$577.1M
Q2 25
$2.6B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.6B
Q2 24
$2.6B
Q1 24
$2.6B
Debt / Equity
AHH
AHH
VRDN
VRDN
Q4 25
2.43×
Q3 25
2.33×
Q2 25
2.22×
Q1 25
2.01×
Q4 24
1.93×
Q3 24
2.00×
Q2 24
2.52×
Q1 24
2.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHH
AHH
VRDN
VRDN
Operating Cash FlowLast quarter
$64.2M
$-84.6M
Free Cash FlowOCF − Capex
$-84.7M
FCF MarginFCF / Revenue
-120.1%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
26.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHH
AHH
VRDN
VRDN
Q4 25
$64.2M
Q3 25
$26.3M
$-84.6M
Q2 25
$11.1M
Q1 25
$107.0K
Q4 24
$112.0M
Q3 24
$27.3M
Q2 24
$17.4M
Q1 24
$46.5M
Free Cash Flow
AHH
AHH
VRDN
VRDN
Q4 25
Q3 25
$-84.7M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
AHH
AHH
VRDN
VRDN
Q4 25
Q3 25
-120.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
AHH
AHH
VRDN
VRDN
Q4 25
Q3 25
0.2%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
AHH
AHH
VRDN
VRDN
Q4 25
26.99×
Q3 25
328.63×
Q2 25
1.87×
Q1 25
Q4 24
4.78×
Q3 24
Q2 24
5.48×
Q1 24
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AHH
AHH

Office Real Estate Segment$28.8M38%
Retail Real Estate Segment$25.4M34%
Multifamily Residential Real Estate$17.7M23%
Real Estate Financing Segment$3.6M5%

VRDN
VRDN

Segment breakdown not available.

Related Comparisons